Brief: Purapharm Calrifies on Rumors Regarding Disruption And Suspension Of Production Facilities

PuraPharm

11/02/2020 14:07

Feb 11 (Reuters) - PuraPharm Corp Ltd  1498.HK :
    * NOTED RUMOURS THAT OPERATION OF CONCENTRATED CHINESE
MEDICINE
GRANULE PRODUCTION FACILITIES IN NANNING, HAVE BEEN DISRUPTED
AND SUSPENDED
    * GROUP PLANS TO INCREASE PRODUCTION AND SUPPLY OF ITS
CHINESE
HEALTHCARE PRODUCTS, ESPECIALLY IMMUZAC
    * NANNING PRODUCTION FACILITIES HAVE RESUMED ITS PRODUCTION
AS
USUAL ON 3 FEB
    * CLARIFIES OPERATION OF CONCENTRATED CHINESE MEDICINE
GRANULE
PRODUCTION FACILITIES IN NANNING, GUANGXI, PRC NOT SUSPENDED

Source text for Eikon:  ID:nHKS4RKyHq 
Further company coverage:  1498.HK 

 ((Reuters.Briefs@thomsonreuters.com;))